Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Raltegravir Potassium Salt

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 993Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2025 Siegfried AG
    Switzerland
    		 MSD Korea Co., Ltd. Su90-21-ND Raltegravir potassium 2017-05-18 Siegfried Evionnaz SA@(Micronization Process) MSD International GmbH (Singapore Branch) Switzerland Route du Simplon 1, 36, 1902 Evionnaz Switzerland@50 Tuas West Drive Singapore 638408
    30/12/2025 Divis Laboratories
    India
    		 MSD Korea Co., Ltd. Su90-20-ND Raltegravir potassium 2017-05-18 Divi's Laboratories Limited@(Undifferentiated Process) MSD International GmbH(Singapore Branch) India Unit-2, Chippada(V) Annavaram(Post), Bheemunipatnam(M) Visakhapatnam District-531 162 Andhra Pradesh, India@50 Tuas West Drive Singapore 638408
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.